Search

everythinglearnresearchcommunity

for

Search:↓

Blocking S100A8 can reduce chemotherapy-induced hair loss.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Epidermal growth factor helps hair recover after chemotherapy.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Finasteride and tamsulosin hydrochloride can be safely taken together without significant interaction.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Pseudomonas DL17 can completely break down the harmful dye Sunset Yellow FCF in 48 hours.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Targeting EGFR may help reduce hair loss from chemotherapy.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.